Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells

• Chiara Riganti ,

  * E-mail: chiara.riganti@unito.it

  Affiliations Department of Oncology, University of Torino, Torino, Italy, Center for Experimental Research and Medical Studies (CeRMS), University of Torino, Torino, Italy

  ⨯
• Barbara Castella,

  Affiliation Center for Experimental Research and Medical Studies (CeRMS), University of Torino, Torino, Italy

  ⨯
• Joanna Kopecka,

  Affiliation Department of Oncology, University of Torino, Torino, Italy

  ⨯
• Ivana Campia,

  Affiliation Department of Oncology, University of Torino, Torino, Italy

  ⨯
• Marta Coscia,

  Affiliations Center for Experimental Research and Medical Studies (CeRMS), University of Torino, Torino, Italy, Division of Hematology, University of Torino, Torino, Italy

  ⨯
• Gianpiero Pescarmona,

  Affiliations Department of Oncology, University of Torino, Torino, Italy, Center for Experimental Research and Medical Studies (CeRMS), University of Torino, Torino, Italy

  ⨯
• Amalia Bosia,

  Affiliations Department of Oncology, University of Torino, Torino, Italy, Center for Experimental Research and Medical Studies (CeRMS), University of Torino, Torino, Italy

  ⨯
• Dario Ghigo,

  Affiliations Department of Oncology, University of Torino, Torino, Italy, Center for Experimental Research and Medical Studies (CeRMS), University of Torino, Torino, Italy

  ⨯
• Massimo Massaia

  Affiliations Center for Experimental Research and Medical Studies (CeRMS), University of Torino, Torino, Italy, Division of Hematology, University of Torino, Torino, Italy

  ⨯